Form 4 Filing: ROBERTS EIRY Acquires (Grant) shares of $NBIX

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

NEUROCRINE BIOSCIENCES INC

Ticker: $NBIX

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-11-04

Shares: 9,820

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ROBERTS EIRY, holds the title of Chief Medical Officer at NEUROCRINE BIOSCIENCES INC.

On 2026-11-04, the insider transacted 9,820 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

ROBERTS EIRY (Chief Medical Officer) was granted $0 of $NBIX

Post-Transaction Position: 8,314 shares

SEC Accession No: 0001727606-26-000007 (CIK: 1727606)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$NBIX Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$NBIX News Coverage